penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Alan J. Wein, MD, FACS, PhD(hon)
Urology

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Administrative Office:
Perelman Center for Advanced Medicine
West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Executive Assistant: Carol R. Martin
215-662-6755
Administrative Telephone: 215-662-2891

Contact Information (internal use only)

Online Chat with Penn Medicine Experts
Prostate Cancer Treatment
Using Proton Therapy
(6ABC News Link)
 
Dr. Wein

ASCO Recommendations Continue the Debate on PSA Testing (Link)

 

 

Alan J. Wein, MD, FACS, PhD(hon) is Professor and Chief of the Division of Urology at the University of Pennsylvania School of Medicine, and Chief of Urology at the Hospital of the University of Pennsylvania and Director of the Residency Program in Urology at the University of Pennsylvania at the Hospital of the University of Pennsylvania. He is a graduate of Princeton University and received his MD from the University of Pennsylvania School of Medicine. He completed training in Surgery and Urology at the University of Pennsylvania including a fellowship at the Harrison Department of Surgical Research. He has been certified and recertified (voluntary) by the American Board of Urology. He was awarded an honorary Ph.D. from the University of Patras, Greece in September 2005.



Dr. Wein has been recognized nationally and internationally through his many affiliations and professional memberships which include the American Association of Genitourinary Surgeons, Clinical Society of Genitourinary Surgeons, American Surgical Association, Society of Surgical Oncology, Society of Urologic Oncology, Society of Pelvic Surgeons, Society for Urodynamics and Female Urology, Société Internationale d’Urologie, American Urological Association (AUA) and the Royal Society of Medicine. He is a recipient of the Urodynamics Society Lifetime Achievement Award, the F. Brantley Scott Award of the American Foundation for Urologic Diseases, the Hugh Hampton Young Award of the American Urological Association, both the Distinguished Service Award and the Distinguished Contribution Award of the American Urological Association, the Achievement Award of the Interstitial Cystitis Association, the William P. Burpeau Award of the New Jersey Academy of Medicine, the Distinguished Service Award of the Society of Urodynamics and Female Urology, and the Ferdinand C. Valentine Award of the New York Academy of Medicine. He has been the Ramon Guiteras lecturer at the AUA annual meeting, the AUA lecturer of the Société Internationale d’Urologie and the European Association of Urology and the British Journal of Urology lecturer at the British Association of Urological Surgeons. He has served on and chaired numerous medical committees and consultations both domestically and internationally, and has received numerous awards and honors for excellence in the field of Urology. He has served on the American Board of Urology (Vice President), the Examination Committee of the American Urological Association and the Residency Review Committee for Urology (Chair). He has held or does hold editorial positions on many well-respected journals including the Survey Section of the Journal of Urology, Neurourology and Urodynamics, Urology, British Journal of Urology International, International Urogynecology Journal, Current Urology Reports, Current Opinion in Urology, Nature Urology, Investigative Urology, Postgraduate Medicine, Advances in Therapy, Current Bladder Dysfunction Reports, Journal of Pelvic Surgery and LUTS. He has been an editor of the textbook considered to be the gold standard in Urology, Campbell-Walsh Urology, since 1992, and is currently the editor-in-chief.

Dr. Wein has authored or co-authored more than 880 articles and chapters, edited or co-edited 28 books, and have multiple multimedia presentations to his credit. His extensive experience in the field of urology has afforded him the opportunity to participate in numerous invited academic activities, meetings, and courses as a speaker, faculty
member and chairperson. He is a prodigious lecturer with over 600 invited academic activities over the course of his career, including the co-chairmanship of the 1st, 2nd, 3rd and 4th International Consultations on Incontinence. Throughout his career, he has been recognized by Philadelphia Magazine and Castle Connolly as a “Top Doc”, and is listed as one of America’s “Best Doctors” by the Best Doctors in America, Inc. His fields of interest are the evaluation and management of urologic cancer, the physiology and pharmacology of the lower urinary tract, the evaluation and management of voiding function and dysfunction including problems related to prostate enlargement, urinary incontinence and neurologic disease.

 
Faculty Appointments
1967 - 1968 Assistant Instructor in Surgery,
University of Pennsylvania School of Medicine
 
1969 - 1971 Assistant Instructor in Urology (Surgery),
University of Pennsylvania School of Medicine
 
1971 - 1972 Instructor in Urology (Surgery)
University of Pennsylvania School of Medicine
 
1974 - 1976 Assistant Professor of Urology (Surgery)
University of Pennsylvania School of Medicine
 
1976 - 1983 Associate Professor of Urology (Surgery with tenure)
University of Pennsylvania School of Medicine
 
1983 - present Professor of Urology (Surgery, with tenure)
Perelman School of Medicine
University of Pennsylvania
 
1990 - present Professor of Surgery (Urology) in Radiology
 
2007 - present Founders Professorship in Urology
(aka) The Alan J. Wein, M.D. Professorship
Perelman School of Medicine
University of Pennsylvania
 
Hospital and Administrative Appointments
1974 - 1979 Assistant Chief of Urology
Hospital of the University of Pennsylvania
 
1974 - 1982 Chief of Urology
Veterans Administration Hospital, Philadelphia
 
1974 - present Assistant Surgeon
Children’s Hospital of Philadelphia
 
1974 - present Director, Urodynamics Evaluation Center
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1975 - 1977 Consultant in Urology
Philadelphia General Hospital
 
1975 - present Director, Residency Program in Urology
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1976 - present Director, Program in Urologic Oncology
Division of Urology
Perelman School of Medicine
University of Pennsylvania
 
1977 - present Associate Surgeon, Pennsylvania Hospital
 
1980 - 1997 1980-1997 Attending Urologist
Graduate Hospital, Philadelphia
 
1979 - 1981 1979-1981 Acting Chief of Urology
Hospital of the University of Pennsylvania,
Acting Chairman, Division of Urology
University of Pennsylvania School of Medicine
 
1981 - present Chairman, Division of Urology
Department of Surgery
Perelman School of Medicine
University of Pennsylvania
 
1981 - present Chief of Urology
Hospital of the University of Pennsylvania
 
1982 - 1996 Attending Urologist
Veterans Administration Hospital, Philadelphia
 
Education/Training
1958 - 1962 Princeton University, A.B
 
1962 - 1966 University of Pennsylvania School of Medicine, M.D.
 
2005 Honorary Ph.D. conferred by University of Patras
Patras, Greece
 
2008 Wharton School of Business
University of Pennsylvania Executive Training Course
   
Postgraduate Training and Fellowship Appointments
1966 - 1967 Mixed Surgical Internship
Hospital of the University of Pennsylvania
   
1967 - 1968 Resident in Surgery
Hospital of the University of Pennsylvania
   
1968 - 1969 Fellow, Harrison Department of Surgical Research (Urology)
University of Pennsylvania School of Medicine
Venereal Disease Resident Trainee
City of Philadelphia
   
1969 - 1972 Resident in Urology
Hospital of the University of Pennsylvania
 
Military Service
1972 - 1974 Major, MC, United States Army, Division of Urology
Martin Army Hospital, Fort Benning, Georgia
 
Memberships/Societies
 
Local
  • American Urological Association, Mid-Atlantic Section
  • College of Physicians of Philadelphia
  • Delaware Valley Society of Transplant Surgeons
  • John Morgan Society
  • Pennsylvania Medical Association
  • Pennsylvania Society of Oncology Hematology
  • Philadelphia Academy of Surgery
  • Philadelphia County Medical Society
  • Philadelphia Urologic Society
  • Ravdin-Rhoads Surgical Society
  • Urological Association of Pennsylvania
National and International
  • Alpha Omega Alpha
  • American Academy of Clinical Neurophysiology
  • American Association for the Advancement of Science
  • American Association for the Surgery of Trauma
  • American Association of Clinical Urologists
  • American Association of Genitourinary Surgeons
  • American Cancer Society
  • American Clinical Neurophysiology Society (formerly the American Electroencephalographic Society)
  • American College of Surgeons
  • American Fertility Society
  • American Institute of Ultrasound in Medicine
  • American Medical Association
  • American Medical Foundation
  • American Society for Pharmacology and Experimental Therapeutics
  • American Society of Andrology
  • American Society of Clinical Oncology
  • American Surgical Association
  • American Uro-Gynecologic Society
  • American Trauma Society
  • American Urological Association
  • American Urological Association Allied
  • Association for Academic Surgery
  • Canadian Urological Association
  • Clinical Society of Genito-Urinary Surgeons
  • Eastern Cooperative Oncologic Group
  • Endourological Society
  • European Association of Urology
  • International Continence Society
  • International Society of Impotence Research
  • Interstitial Cystitis Association
  • National Association for Continence
  • National Association of Veterans Administration Physicians
  • National Kidney Foundation, Inc. Council on Urology
  • New York Academy of Sciences
  • Radiation Therapy Oncology Group
  • Royal Society of Medicine
  • Sexual Medicine Society of North America, Inc.
  • Sigma Xi
  • Simon Foundation
  • Société Internationale d’Urologie
  • Société Internationale de Chirurgie
  • Society for Basic Urological Research
  • Society for Minimally Invasive Surgery
  • Society for the Study of Impotence
  • Society for Sex Therapy and Research
  • Society for Urodynamics and Female Urology-SUFU (Formerly the Urodynamics Society)
  • Society of Government Service Urologists
  • Society of Pelvic Surgeons
  • Society of Surgical Oncology
  • Society of University Surgeons
  • Society of University Urologists
  • Society of Urology Chairs and Program Directors
  • Society of Urologic Cryosurgeons
  • Society of Urologic Oncology (Founding member)
  • University Urologic Forum (now defunct)
  • Urologic Investigators Forum (now defunct)
  • Urologic Research Society
  • Urologists Correspondence Club (now defunct)
 
Research
 
Clinical and Research Activities and Interests
Dr. Wein's clinical expertise and interests are primarily in the fields of urologic cancer and voiding function and dysfunction. He was one of the founding members of the Society of Urologic Oncology and was elected to membership in the other two groups that are concerned with the evaluation and management of cancer: The American Society of Clinical Oncology and the Society of Surgical Oncology. He has particular interest and expertise in the area of prostate cancer and serves as a member of the International Consultation in prostate cancer. Dr. Wein's expertise in the areas of voiding function and dysfunction are widely acknowledged, particularly in the areas of urinary incontinence, neurogenic dysfunction, overactive bladder, interstitial cystitis, and dysfunction secondary to prostate enlargement. He serves on the International Consultation for both urinary incontinence (of which he is co-chair) and benign prosatic hyperplasia. He has been on the faculty of and directed numerous seminars in these areas. His basic research has been in the area of the physiology and pharmacology of the lower urinary tract, with many important discoveries coming out of his laboratory, beginning in 1970 with progress continuing until the present. These include many of the initial studies on autonomic receptor type and binding in the lower urinary tract; the correlation between pharmacological characteristics and function of the bladder and urethra; the correlation of neuroanatomy, neurophysiology and neuropharmacology of the lower urinary tract, and the effects of outlet obstruction on bladder smooth muscle: anatomy, physiology, pharmacology, and function. His clinical research has been in the areas of urologic cancer (prostate, bladder, kidney, testicle) and in the areas of urinary incontinence, voiding difficulties secondary to prostatic enlargement, to neurologic disease or injury, interstitial cystitis, and in the area of techniques to evaluate patients with voiding problems.
 
Publications
 
Dr. Wein has over 800 publications in print and has been an editor or co-editor of 28 urologic texts or books. He is currently the Editor-in-Chief of Campbell-Walsh Urology, acknowledged to be the gold standard text in the field. He is a consultant to the American Urological Association Office of Education and is the director of its educational series, Practical Cases in Urology. He currently is on the editorial boards of the following journals: Neurourology and Urodynamics (Deputy Editor), British Journal of Urology International (Associate Editor), Urology (Associate Editor), World Journal of Urology, Family Urology, Current Advances in Therapy, and the International Urogynecology Journal.
 
Publications (last 4 years)
  1. Wein AJ. The Urology Report: Selected Reports from the 2006 Annual Meeting of the American Urological Association, Direct One Communications, Inc., 2007.
  2. Wein AJ. Pathophysiology and Classification of Voiding Dysfunction in Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp.1973-1985.
  3. Wein AJ. Lower Urinary Tract Dysfunction and Neurologic Injury and Disease in Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2011-2045.
  4. Andersson K-E, Wein AJ. Pharmacologic Management of Storage and Emptying Failure in Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2091-2123.
  5. Moy ML, Wein AJ. Additional Therapies for Storage and Emptying Failure in Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh Urology Ninth Edition Saunders/Elsevier, Philadelphia, PA 2007, pp. 2288-2304.
  6. Wein AJ. Pathophysiology and Classification of Voiding Dysfunction. Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 251-254.
  7. Wein AJ. Lower Urinary Tract Dysfunction in Neurologic Injury and Disease. Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 262-267.
  8. Andersson K-E, Wein AJ. Pharmacologic Management of Storage and Emptying Failure. Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 275-280.
  9. Moy ML, Wein AJ. Additional Therapies for Storage and Emptying Failure. Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007, pp. 313-315.
  10. Wein AJ, Moy ML. Voiding Function and Dysfunction; Urinary Incontinence. Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 341-478.
  11. Wein AJ, Lee DI. Benign Prostatic Hyperplasia and Related Entities. Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 479-522.
  12. Malkowicz SB, Vaughn DJ, Wein AJ. Adult Genitourinary Cancer – Prostate and Bladder. Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Philadelphia, PA 2007, pp 523-570.
  13. Guzzo TJ, Vira MA, Neway W, Hwang W-T, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz SB. Minimal Tumor Volume May Provide Additional Prognostic Information in Good Performance Patients After Radical Prostatectomy. Elsevier, Inc., Urology 2007; 69:1147-1151.
  14. Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European-American Men. J Urol 178:1939-1944, 2007.
  15. Jayadevappa R, Johnson JC, Chhatre S, Wein AJ, Malkowicz SB. Ethnic Variation in Return to Baseline Values of Patient-Reported Outcomes in Older Prostate Cancer Patients. American Cancer Society – Cancer 2007; 109:2229-2238.
  16. Wein AJ, Dmochowski RR. Strategies for data comparison for drugs used in the treatment of overactive bladder. The Overactive Bladder Evaluation and Management, Informa Healthcare (Informa UK, Ltd) 2007; pp 239-252.
  17. Kasturi S, Kutikov A, Guzzo TJ, Smith AL, Wein AJ. Modern management of pheochromocytoma. Nature Clinical Practice Urology, 2007; Vol 4:11:pp 630-633.
  18. Lee U, Baskin L, Schaefer W, Lemack GE, Wein AJ, Daneshgari F. Highlights of the Urethral Dysfunction Sessions at the Society for Urodynamics and Female Urology. Current Bladder Dysfunction Reports 2007, 2:71-76.
  19. Griffiths D, Abrams P, D’Ancona CA, van Kerrebroeck P, Nishizawa O, Nitti VW, Tatt FK, Tubaro A, Wein AJ, Belal M. The Urodynamic Evaluation of Lower Urinary Tract Symptoms in Men. Current Bladder Dysfunction Reports 2008, 3;Vol 1:49-57.
  20. Vira MA, Guzzo T, Heitjan DF, Tomaszewski JE, D’Amico§, Wein AJ, Malkowicz SB. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? British Journal of Urology International, 2008; Vol 101:pp 1232-1236.
  21. Wein AJ, Moy ML. Categorization of Voiding Dysfunction. Female Urology, Third Edition, 2008; pp 161-171.
  22. Wein AJ, Moy ML. Drug Treatment of Urinary Incontinence in Women. Female Urology, Third Edition, 2008; pp 233-256.
  23. Cetnar JP, Malkowicz SB, Palmer SC, Wein AJ, Vaughn DJ. Pilot trial of adjuvnt paclitaxel plus estramustine in resected, High-risk prostate cancer. Urology 71:942-946, 2008.
  24. Chapple CR, Wein AJ, Abrams P, Dmochowski RR, Guiliano F, Kaplan SA, McVary KT, Roehrborn CG. Lower urinary tract symptoms revisited: A broader clinical perspective. European Urology 54:563-569, 2008.
  25. Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition. J Urol 2008, 180:47-54.
  26. Canter D, Guzzo TJ, Resnick MJ, Brucker B, Vira M, Chen Z, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz SB. Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology. 2008;72:379-383.
  27. Guzzo TJ, Kutikov A, Canter DJ, Tomaszewski JE, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Can J Urol. 2008;15:4174-4178; discussion 4179.
  28. Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C. Joint effects of inflammation and androgen metabolism on prostate cancer severity. Int J Cancer. 2008;123:1385-1389.
  29. Resnick MJ, Canter D, Brucker BM, Kutikov A, Guzzo TJ, Wein AJ. A case of synchronous bilateral testicular seminoma. Nat Clin Pract Urol. 2008;5:397-401.
  30. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological Treatment of Urinary Incontinence. INCONTINENCE, 4th Edition, Health Publication, Ltd; 631-700, 2009.
  31. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Pharmacological Treatment of Overactive Bladder: report from the International Consultation on Incontinence. Current Opinion In Urology 2009,19:380-394.
  32. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, DuBeau C, Fry C, Hanno P, Hay Smith J, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek DB, Wein A, Wyndaele JJ, et al. 4th International Consultation on Incontinence, Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse and Faecal Incontinence. INCONTINENCE, 4th Edition, Health Publication, Ltd; 1767-1820, 2009.
  33. Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, Aiyer LP. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 4-11, April 2009.
  34. Sexton CC, Coyne KS, Kopp ZS, Irwin DE, Milsom I, Aiyer LP, Tubaro A, Chapple CR, Wein AJ on behalf of the EpiLUTS Team. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 12-23, April 2009.
  35. Wein AJ, Coyne KS, Tubaro A, Sexton CC, Kopp ZS, Aiyer LP. The impact of lower urinary tract symptoms on male sexual health: EpiLUTS. British Journal of Urology International (BJUI), 103:suppl.3; pp 33-41, April 2009.
  36. Hypolite JA, Chang S, LaBelle E, Babu GJ, Periasamy M, Wein AJ, Chacko S. Deletion of SM-B, the high ATPase isoform of myosin, upregulates the PKC-mediated signal transduction pathway in murine urinary bladder smooth muscle. Am J Physiol Renal Physiol. 2009 Mar;296(3):F658-665. Epub 2008 Dec 3.
  37. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad SS, Wein AJ, Malkowicz SB. Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology. 2009 Mar;73(3):620-623. Epub 2008 Dec 18.
  38. Hall SA, Link CL, Tennstedt SL, Mollon P, Aiyer LP, Chapple CR, Wein AJ, Rosen RC. Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey. BJU Int. 2009 Jun; 103(11):1502-1508 Epub 2009 Jan 14.
  39. Chang S, Hypolite JA, Mohanan S, Zderic SA, Wein AJ, Chacko S. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab Invest. Jul 2009;89:823-832.
  40. Jayadevappa R, Chhatre S, Wein AJ, Malkowicz SB. Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer. The Prostate 2009 Jul;69:1067-1076.
  41. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, Chapple CR, Kaplan S, Tubaro A, Aiyer LP, Wein AJ. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009 Aug; 104(3);352-360. Epub 2009 Mar 5.
  42. Basha M, LaBelle EF, Northington GM, Wang T, Wein AJ, Chacko S. Functional significance of muscarinic receptor expression within the proximal and distal rat vagina. Am J Physiol Regul Integr Comp Physiol 297:R1486-R1493, 3 September 2009.
  43. Ellsworth PI, Brunton SA, Wein AJ, Rovner ES. Frequently asked questions in the evaluation and management of overactive bladder. An Expert Panel Review. Supplement to The Journarl of Family Practice, Vol 58, No. 10, October 2009.
  44. Resnick MJ, Canter DJ, Guzzo TJ, Magerfleisch L, Tomaszewski JE, Brucker BM, Bergey MR, Sonnad SS, Wein AJ, Malkowicz SB. Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. BJU International (accepted Jul 2009; published online Nov 2009).
  45. Polyák E, Boopathi E, Mohanan S, Deng M, Zderic SA, Wein AJ, Chacko S. Alterations in Caveolin Expression and Ultrastructure After Bladder Smooth Muscle Hypertrophy. J Urol 182(5):2497-2503 November 2009.
  46. Cardozo L, Chapple C, Wein A. Urgency as the cardinal symptom of overactive bladder: a critical analysis. World J Urol 2009 Dec; 27(6):701-703. Epub 2009 Nov 15.
  47. Andersson K-E, Dmochowski R, Wein AJ. Minimally Invasive Therapy for Neurogenic Detrusor Overactivity: A Review. UroToday International Journal Vol 2(6) Dec 2009.
  48. Smith AL, Wein AJ. Recent advances in management of bladder overactivity. F1000 Medicine Reports 2010, 2:9.
  49. Hanno P, Lin A, Nordling J, Nyberg L, van Ophoven A, Ueda T, Wein A. Bladder Pain Syndrome International Consultation on Incontinence. NeurourolUrodyn 29(1):191-198, 2010.
  50. Wyndaele JJ, Bruschini H, Madersbacher H, Moore K, Pontari M, Wein A. Neurological Patients Need Evidence-Based Urological Care. Neurourol Urodyn 2010 Apr;29(4):662-669.
  51. Resnick MJ, Guzzo TJ, Canter DJ, Tomaszewski JE, Bergy MR, Sonnad S, Wein AJ, Malkowicz SB. Defining pathologic parameters to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: Implications for adjuvant radiation therapy. BJU International Vol 105(10)pp.1377-1380(4) May 2010. (Epub Nov 2009).
  52. Chang S, Gomes CM, Hypolite JA, Marx J, Alanzi J, Zderic SA, Malkowicz B, Wein AJ, Chacko S. Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein. Am J Phys – Renal Phys 298(6):F1416-23, Jun 2010. (Epub 4-2010).
  53. Recent advances in the development of antimuscarinic agents for overactive bladder. Smith AL, Wein AJ. Trends Pharmacol Sci. 2010 Oct:31(10):470-5.
Books (last 4 years)
  1. Hanno PM, Malkowicz SB, Wein AJ: Penn Clinical Manual of Urology, 1st Edition, Saunders/Elsevier, Inc., Philadelphia, PA 2007.
  2. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh Urology Ninth Edition, Saunders/Elsevier, Philadelphia, PA 2007.
  3. Wein AJ (editor-in-chief), Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh Urology Ninth Edition Review, Saunders/Elsevier, Philadelphia, PA 2007.
  4. Slack A, Jackson S, Wein AJ: Fast Facts: Bladder Disorders. Health Press Limited, Oxford, UK, 2008 (Courtesy distribution Dec 2007; available to the public Jan 2008).
  5. Newman DK, Wein AJ: Managing and Treating Urinary Incontinence, 2nd Edition, Health Professions Press, Inc., Baltimore, Maryland, 2009.
  6. Abrams, P, Cardozo, L, Khoury, S, Wein, AJ (eds): INCONTINENCE. 4th International Consultation on Incontinence (ICI), July 5-8, 2008, Paris, France. Health Publication Ltd, 2009.
  7. Ellsworth P, Wein AJ. Questions & Answers About Overactive Bladder, 2nd Edition, Jones and Bartlett Publishers, Sudbury, MA, Copyright © 2010.
Abstracts, Editorials (last 4 years)
  1. Wein AJ: Selective Beta-Adrenoceptor Agonists, Calcium Antagonists and Potassium Channel Openers as a Possible Medical Treatment of the Overactive Bladder and Urge Incontinence. J Urol January 2007, 177:230.
  2. Wein AJ: Transurethral Radiofrequency Energy Collagen Micro-Remodeling for the Treatment of Female Stress Urinary Incontinence. J Urol January 2007, 177:231.
  3. Wein AJ: Objective and Subjective Cure Rates After Trans-Obturator Tape (OBTAPE) Treatment of Female Urinary Incontinence. J Urol January 2007, 177:232.
  4. Wein AJ: A Nationwide Analysis of Transvaginal Tape Release of Urinary Retention After Tension-Free Vaginal Tape Procedure. J Urol January 2007, 177:232-233.
  5. Wein AJ: The Efficacy of the Tension-Free Vaginal Tape in the Treatment of Five Subtypes of Stress Urinary Incontinence. J Urol January 2007, 177:233.
  6. Wein AJ: M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. I. Normal Rat Bladder. J Urol January 2007, 177:401-402.
  7. Wein AJ: M2 and M3 Muscarinic Receptor Activation of Urinary Bladder Contractile Signal Transduction. II. Denervated Rat Bladder. J Urol January 2007, 177.402-403.
  8. Wein AJ: Introduction to the 2005 IUGA Grafts Roundtable: Clinical Implications of the Biology of Grafts: Conclusions of the 2005 IUGA Grafts Roundtable. J Urol February 2007, 177:620-621.
  9. Wein AJ: Synthetic Biomaterials for Pelvic Floor Reconstruction. J Urol February 2007, 177:622.
    370. Wein AJ: The Use of Synthetic Mesh in Female Pelvic Reconstructive Surgery. J Urol February 2007, 177:622-623.
  10. Wein AJ: Preliminary Results on the Off-Label Use of Duloxetine for the Treatment of Stress Incontinence After Radical Prostatectomy or Cystectomy. J Urol March 2007, 177:963-964.
  11. Wein AJ: Is HCI Duloxetine Effective in the Management of Urinary Stress Incontinence After Radical Prostatectomy? J Urol March 2007, 177:964.
  12. Wein AJ: Ultrasound Measurement of Detrusor Wall Thickness in Healthy Adults. J Urol March 2007, 177:1052.
  13. Wein AJ: Effects of Potassium Channel Modulators on Human Detrusor Smooth Muscle Myogenic Phasic Contractile Activity: Potential Therapeutic Targets for Overactive Bladder. J Urol March 2007, 177:1052-1053.
  14. Wein AJ: 1) Botulinum Toxin-Type A in the Treatment of Drug-Resistant Neurogenic Detrusor Overactivity Secondary to Traumatic Spinal Cord Injury. 2) Therapeutic Effects of Suburothelial Injection of Botulinum A Toxin for Neurogenic Detrusor Overactivity Due to Chronic Cerebrovascular Accident and Spinal Cord Lesions. J Urol March 2007, 177:1053-1054.
  15. Wein AJ: Five-Year Outcomes of the Tension-Free Vaginal Tape Procedure for Treatment of Female Stress Urinary Incontinence. J Urol April 2007, 177:1427.
  16. Wein AJ: Tension-Free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence With Intrinsic Sphincteric Deficiency. J Urol April 2007, 177:1427-1428.
  17. Wein AJ: A Randomized Controlled Equivalence Trial of Short-Term Complications and Efficacy of Tension-Free Vaginal Tape and Suprapubic Urethral Support Sling for Treating Stress Incontinence. J Urol April 2007, 177:1428-1429.
  18. Wein AJ: Various Surgical Approaches to Treat Voiding Dysfunction Following Anti-Incontinence Surgery. J Urol April 2007, 177:1429-1430.
  19. Spangler E, Malkowicz SB, Zeigler-Johnson C, Van Arsdalen K, Wein AJ, Rebbeck TR. Body Mass Index Correlates With Tumor Characteristics and Biochemical Failure in African-American Men. J Urol Supplement 177(4):96, April 2007.
  20. Jayavedappa R, Chhatre S, Whittington R, Wein AJ, Malkowicz SB. Assessment of Indirect Costs of Newly Diagnosed Prostate Cancer Patients. J Urol Supplement 177(4):97, April 2007.
  21. Boopathi E, Mohanan S, Zheng Y, Wein AJ, Chacko S. Urologic Complications of Diabetes: High Glucose-Induced Oxidative Stress Activates The Transcriptional Factor NF-KB in the Detrusor Smooth Muscle Cells. J Urol Supplement 177(4):324, April 2007.
  22. Marx JO, Basha M, Mohanan S, Hypolite J, Chang S, Hu E, Sulpizio A, Malkowicz SB, Wein AJ, Laping NJ, Chacko S. Rho-Kinase Inhibitor Decreases Spontaneous Activity in Detrusor Smooth Muscle with Partial Bladder Outlet Obstruction. J Urol Supplement 177(4):325, April 2007.
  23. Hypolite J, Chang S, Zderic SA, Wein AJ, Chacko S. Bladder Dysfunction is Associated with Impaired Contractility and Decreased Density of Nerve Fiber in The Rabbit Model of Partial Bladder Outlet Obstruction. J Urol Supplement 177(4):326, April 2007.
  24. Abraham N, Guzzo TJ, Tomaszewski JE, Chen Z, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. Estimated Tumor Volume Provides Independent Predictive Information on Biochemical Outcome in High Grade Radical Prostatectomy Patients. J Urol Supplement 177(4):466, April 2007.
  25. Basha M, Wang T, Lassmann J, Moreland RS, Wein AJ, Chacko S. Estrogen Upregulates Smooth Muscle Myosin Isoform SM2 in the Rat Vaginal Wall. J Urol Supplement 177(4):483, April 2007.
  26. Chang S, Basha M, Wein AJ, Chacko S. Estrogen-Depletion Induces The Up-Regulation of the Regulatory Pathway Involved in the Maintenance of Tone in the Lower Urinary Tract Smooth Muscle. J Urol Supplement 177(4):487, April 2007.
  27. Guzzo TJ, Canter DJ, Tomaszewski JE, Magerfleish L, VanArsdalen K, Wein AJ, Malkowicz SB. The Antecedent History of High Grade Prostatic Intraepithelial Neoplasia in a Radical Prostatectomy Cohort. J Urol Supplement 177(4):584, April 2007.
  28. Malkowicz SB, Zeigler-Johnson C, Spangler E, Panossian S, Wein AJ, Rebbeck TR. Obesity is Associated with Poorer Clinical Outcomes in Prostate Cancer Patients with High-Risk Androgen Receptor Genotypes. J Urol Supplement 177(4):588, April 2007.
  29. Jayadevappa R, Chhatre S, Whittington R, Wein AJ, Malkowicz SB. Hospital Ownership and Quality of Prostate Cancer Care. J Urol Supplement 177(4):592, April 2007.
  30. Wein AJ: Reevaluating Occult Incontinence. J Urol May 2007, 177:1820-1821.
  31. Wein AJ: Neurological Disease That Cause Detrusor Hyperactivity With Impaired Contractile Function. J Urol May 2007, 177:1821.
  32. Wein AJ: Antimuscarinic Drugs in Detrusor Overactivity and the Overactive Bladder Syndrome: Motor or Sensory Actions? J Urol May 2007, 177:1822-1823.
  33. Wein AJ: Botulinum Toxin Injections for Neurogenic and Idiopathic Detrusor Overactivity: A Critical Analysis of Results. J Urol June 2007, 177:2242.
  34. Wein AJ: Will Suburothelial Injection of Small Dose of Botulinum A Toxin Have Similar Therapeutic Effects and Less Adverse Events for Refractory Detrusor Overactivity? J Urol June 2007, 177:2243.
  35. Wein AJ: Persistence of Therapeutic Effect After Repeated Injections of Botulinum Toxin Type A to Treat Incontinence due to Neurogenic Detrusor Overactivity. J Urol June 2007, 177:2244.
  36. Wein AJ: Sustained Beneficial Effects of Intraprostatic Botulinum Toxin Type A on Lower Urinary Tract Symptoms and Quality of Life in Men With Benign Prostatic Hyperplasia. J Urol June 2007, 177:2244-2245.
  37. Wein AJ: The Effects of a New Selective Beta3-Adrenoceptor Agonist (GW427353) on Spontaneous Activity and Detrusor Relaxation in Human Bladder. J Urol June 2007, 177:2245.
  38. Wein AJ: The Effect of Cannabis on Urge Incontinence in Patients With Multiple Sclerosis: A Multicentre, Randomised Placebo-Controlled Trial (CAMS-LUTS). J Urol June 2007, 177:2246.
  39. Wein AJ: Different Brain Effects During Chronic and Acute Sacral Neuromodulation in Urge Incontinent Patients With Implanted Neurostimulators. J Urol June 2007, 177:2246-2247.
  40. Wein AJ: Recommendations for Urodynamic Assessment in the Evaluation of Women With Stress Urinary Incontinence. J Urol July 2007, 178:217.
  41. Wein AJ: A Prospective Observational Trial of Pelvic Floor Muscle Training for Female Stress Urinary Incontinence. J Urol July 2007, 178:217-218.
  42. Wein AJ: A Randomized Controlled Trial of the Effectiveness of Pelvic Floor Therapies for Urodynamic Stress and Mixed Incontinence. J Urol July 2007, 178:218-219.
  43. Wein AJ: 1) The Motion: Injectables are Justified as a First Option for Stress Urinary Incontinence. 2) Injectables are Justified as a First Option for Stress Urinary Incontinence: Against the Motion. J Urol July 2007, 178:219-220.
  44. Wein AJ: Is it Possible to Improve Elderly Male Bladder Function by Having Them Drink More Water? A Randomized Trial of Effects of Increased Fluid Intake/Urine Output on Male Lower Urinary Tract Function. J Urol July 2007, 178:220.
  45. Wein AJ: Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder: A Randomized Controlled Trial. J Urol July 2007, 178:220-221.
  46. Wein AJ: Duloxetine Treatment for Women Awaiting Continence Surgery. J Urol August 2007, 178:584.
  47. Wein AJ: TVT vs Monarc: A Comparative Study. J Urol August 2007, 178:584-585.
  48. Wein AJ: Childbearing After TVT: How I Have my Baby When I Have a TVT. J Urol August 2007, 178:585.
  49. Wein AJ: Male Bulbourethral Sling After Radical Prostatectomy: Intermediate Outcomes at 2 to 4-Year Followup. J Urol August 2007, 178:585-586.
  50. Wein AJ: Naftopidil Monotherapy vs Naftopidil and an Anticholinergic Agent Combined Therapy for Storage Symptoms Associated With Benign Prostatic Hyperplasia: A Prospective Randomized Controlled Study. J Urol August 2007, 178:586-587.
  51. Wein AJ: Estrogen Therapy and Urinary Incontinence: What Is the Evidence and What Do We Tell Our Patients? J Urol September 2007, 178:1002.
  52. Wein AJ: Health Care Discussions and Treatment for Urinary Incontinence in U.S. Women. J Urol September 2007, 178:1002-1003.
  53. Wein AJ: A Prospective Observational Trial of Pelvic Floor Muscle Training for Female Stress Urinary Incontinence. J Urol September 2007, 178:1003-1004
  54. Wein AJ: The Treatment of Female Bladder Outlet Obstruction. J Urol September 2007, 178:1004.
  55. Wein AJ: Recurrent Stress Incontinence is Associated With Decreased Neuromuscular Function in the Striated Urethral Sphincter. J Urol September 2007, 178:1004-1005.
  56. Wein AJ: Prospective Randomized Comparison of Transobturator Suburethral Sling (Monarc) vs Suprapubic Arc (Sparc) Sling Procedures for Female Urodynamic Stress Incontinence. J Urol October 2007, 178:1381.
  57. Wein AJ: Multicenter Experience With the Monarc Transobturator Sling System to Treat Stress Urinary Incontinence. J Urol October 2007, 178:1381-1382.
  58. Wein AJ: Is Transobturator Tape as Effective as Tension-Free Vaginal Tape in Patient With Borderline Maximum Urethral Closure Pressure? J Urol October 2007, 178:1382.
  59. Wein AJ: Transobturator Tape Sling for Female Stress Incontinence With Polypropylene Tape and Outside-In Procedure: Prospective Study With 1 Year of Minimal Follow-Up and Review of Transobturator Tape Sling. J Urol October 2007, 178:1383.
  60. Wein AJ: Tension-Free Vaginal Tape for the Treatment of Urodynamic Stress Incontinence With Intrinsic Sphincteric Deficiency. J Urol October 2007, 178:1383-1384.
  61. Wein AJ: Role of Bladder Neck Mobility and Urethral Closure Pressure in Predicting Outcome of Tension-Free Vaginal Tape (TVT) Procedure. J Urol October 2007, 178:1384.
  62. Wein AJ: Outcome of Tension-Free Vaginal Tape Procedure When Complicated by Intraoperative Cystotomy. J Urol October 2007, 178:1385.
  63. Wein AJ: Overactive Bladder. J Urol November 2007, 178:2055.
  64. Wein AJ: Urinary Incontinence After Hysterectomy—Three-Year Observational Study. J Urol November 2007, 178:2056.
  65. Wein AJ: Impact of Parkinson’s Disease on Continence After Radical Prostatectomy. J Urol November 2007, 178:2056-2057.
  66. Wein AJ: The Role of Ca2+ Influx and Intracellular Ca2+ Release in the Muscarinic-Mediated Contraction of Mammalian Urinary Bladder Smooth Muscle. J Urol November 2007, 178:2220.
  67. Wein AJ: Burch Colposuspension Versus Fascial Sling to Reduce Urinary Stress Incontinence. J Urol December 2007, 178:2501-2502..
  68. Wein AJ: Laparoscopic Colposuspension for Urinary Incontinence in Women. J Urol December 2007, 178:2502-2503.
  69. Wein AJ: Treatment Options for Patients With Suboptimal Response to Surgery for Stress Urinary Incontinence. J Urol December 2007, 178:2503-2504.
  70. Wein AJ: Gabapentin Treatment of Neurogenic Overactive Bladder. J Urol December 2007, 178:2504-2505.
  71. Wein AJ: Prevalence and Risk Factors for Urinary Incontinence in Women With Type 2 Diabetes and Impaired Fasting Glucose: Findings From the National Health and Nutrition Examination Survey (NHANES) 2001-2002. J Urol January 2008, 179:232.
  72. Wein AJ: Retropubic Compared With Transobturator Tape Placement in Treatment of Urinary Incontinence: A Randomized Controlled Trial. J Urol January 2008, 179:233.
  73. Wein AJ: Tension-Free Vaginal Tape (TVT) and Intravaginal Slingplasty (IVS) for Stress Urinary Incontinence: A Multicenter Randomized Trial. J Urol January 2008, 179:234.
  74. Wein AJ: Is Transobturator Tape as Effective as Tension-Free Vaginal Tape in Patients With Borderline Maximum Urethral Closure Pressure? J Urol January 2008, 179:234-235.
  75. Wein AJ: Clinical Relevance of Urodynamic Investigation Tests Prior to Surgical Correction of Genital Prolapse: A Literature Review. J Urol January 2008, 179:235-236.
  76. Wein AJ: EGF and HB-EGF Modulate Inward Potassium Current in Human Bladder Urothelial Cells From Normal and Interstitial Cystitis Patients. J Urol February 2008, 179:562-563.
  77. Wein AJ: BXL-628, a Vitamin D Receptor Agonist Effective in Benign Prostatic Hyperplasia Treatment, Prevents RhoA Activation and Inhibits RhoA/Rho Kinase Signaling in Rat and Human Bladder. J Urol February 2008, 179:622.
  78. Wein AJ: Assessment of the Impact of Sildenafil Citrate on Lower Urinary Tract Symptoms in Men With Erectile Dysfunction. J Urol February 2008, 179:623.
  79. Wein AJ: Bipolar Transurethral Resection of the Prostate—Technical Modifications and Early Clinical Experience. J Urol February 2008, 179:624.
  80. Wein AJ: Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic Review. J Urol March 2008, 179:1047.
  81. Wein AJ: Transobturator Tape for Treatment of Female Stress Urinary Incontinence: Objective and Subjective Results After a Mean Follow-Up of Two Years. J Urol March 2008, 179:1048.
  82. Wein AJ: Outcome of Transvaginal Radiofrequency for Treatment of Women With Stress Urinary Incontinence. J Urol March 2008, 179:1048-1049.
  83. Wein AJ: Transvaginal Urethrolysis for Obstruction After Antiincontinence Surgery. J Urol March 2008, 179:1049-1050.
  84. Wein AJ: Mid-Urethral Slings: Surgical Evolution as Manifest by Technology. J Urol March 2008, 179:1050.
  85. Wein AJ: 1. Efficacy of the InVance Male Sling in Men With Stress Urinary Incontinence. 2. Urethral Compression for the Treatment of Postprostatectomy Urinary Incontinence: Is History Repeating Itself? J Urol March 2008, 179:1050-1051.
  86. Wein AJ: 1. Phosphodiesterase Type 5 Inhibitors: The Day After. 2. Relaxation of Phasic Contractile Activity of Human Detrusor Strips by Cyclic Nucleotide Phosphodiesterase Type 4 Inhibition. J Urol March 2008, 179:1051-1052.
  87. Wein AJ: Bladder Diary Measurements in Asymptomatic Females: Functional Bladder Capacity, Frequency, and 24-Hr Volume. J Urol April 2008, 179:1480.
  88. Wein AJ: Reference Urodynamic Values for Stress Incontinent Women. J Urol April 2008, 179:1480-1481.
  89. Wein AJ: Does Urodynamic Investigation Improve Outcome in Patients Undergoing Prolapse Surgery? J Urol April 2008, 179:1481-1482.
  90. Wein AJ: What’s a “Cure”? Patient-Centred Outcomes of Treatments for Stress Urinary Incontinence. J Urol April 2008, 179:1482-1483.
  91. Wein AJ: Rho Kinase: A Target for Treatment of Urinary Bladder Dysfunction? J Urol April 2008, 179:1483.
  92. Wein AJ: The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Urol April 2008, 179:1483-1484.
  93. Mucksavage P, Mitchell CR, Kutikov A, Wein AJ, Torigian DA, Malkowicz SB. Anthropomorphic Differences In Obese Men With Biochemical Failure After Radical Retropublic Prostatectomy. J Urol Supplement 179(4):67, April 2008.
  94. Brucker BM, Bergey M, Resnick MJ, Sonnad A, Canter D, Guzzo TJ, Rebbeck TR, Wein AJ, Malkowicz SB. The Impact of Obesity on Biochemical Failure After Radical Prostatectomy in African-American and European-American Patients. J Urol Supplement 179(4):152, April 2008.
  95. Jayadevappa R, Chhatre S, Weiner M, Soldo B, Wein AJ, Malkowicz SB. Variations in Care of Older Men with Prostate Cancer. J Urol Supplement 179(4):162, April 2008.
  96. Coyne KS, Sexton C, Kopp ZS, Irwin D, Milsom I, Aiyer L, Wein AJ, Chapple CR, Tubaro A. The Impact of Lower Urinary Tract Symptoms on Men’s Sexual Health: Results from EpiLUTS. J Urol Supplement 179(4):361, April 2008.
  97. Ettickan B, John M, Zderic SA, Wein AJ, Chacko S. The Effect of Partial Bladder Outlet Obstruction on Caveolin: Role of Gata-6 in Transcriptional Regulation of Caveolin-1 Gene Expression in Murine Detrusor Smooth Muscle. J Urol Supplement 179(4):450, April 2008.
  98. Coyne KS, Sexton C, Kopp ZS, Thompson C, Irwin D, Milsom I, Chapple CR, Tubaro A, Wein AJ. The Impact of Lower Urinary Tract Symptoms on Women’s Sexual Health: Results from EpiLUTS Study. J Urol Supplement 179(4):536, April 2008.
  99. Zheng Y, Malkowicz SB, Mohanan S, Chang S, Wein AJ, Chacko S. Generation of a Human Detrusor Smooth Cell Line. J Urol Supplement 179(4):537, April 2008.
  100. Chang S, Hypolite J, Marx J, Zderic SA, Wein AJ, Chacko S. The Role of Large Conductance Calcium and Voltage-Activated Potassium Channel (BK) in Detrusor Overactivity Induced by Partial Bladder Outlet Obstruction. J Urol Supplement 179(4):539, April 2008.
  101. Wein AJ: Prevalence and Correlates for Interstitial Cystitis Symptoms in Women Participating in a Health Screening Project. J Urol May 2008, 179(5):1864-1865
  102. Wein AJ: Potassium Sensitivity Test (PST) as a Measurement of Treatment Efficacy of Painful Bladder Syndrome/Interstitial Cystitis: A Prospective Study with Cyclosporine A and Pentosan Polysulfate Sodium. J Urol May 2008, 179(5):1865.
  103. Wein AJ: Prevalence of Incontinence in Women With Benign Joint Hypermobility Syndrome. J Urol May 2008, 179(5):1923.
  104. Wein AJ: Incidence and Remission of Urinary Incontinence After Hysterectomy—A 3-Year Follow-Up Study. J Urol May 2008, 179(5):1923-1924.
  105. Wein AJ: The Presence of Fowler’s Syndrome Predicts Successful Long-Term Outcome of Sacral Nerve Stimulation in Women With Urinary Retention. J Urol May 2008, 179(5):1924-1925.
  106. Wein AJ: Post-Stroke Urinary Incontinence With Impaired Awareness of the Need to Void: Clinical and Urodynamic Features. J Urol May 2008, 179(5):1925-1926.
  107. Wein AJ: Extracorporeal Magnetic Stimulation is of Limited Clinical Benefit to Women With Idiopathic Detrusor Overactivity: A Randomized Sham Controlled Trial. J Urol June 2008, 179(6):2296-2297.
  108. Wein AJ: Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results After Five Injections in Patients With Neurogenic Detrusor Overactivity. J Urol June 2008, 179(6):2297-2298.
  109. Wein AJ: Tension-Free Midurethral Slings in the Treatment of Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis of Randomized Controlled Trials of Effectiveness. J Urol June 2008, 179(6):2298-2299.
  110. Wein AJ: Tension-Free Vaginal Tape Versus Transobturator Tape as Surgery for Stress Urinary Incontinence: Results of a Multicentre Randomised Trial. J Urol June 2008, 179(6):2299-2300.
  111. Wein AJ: Diagnostic Accuracy of Noninvasive Tests to Evaluate Bladder Outlet Obstruction in Men: Detrusor Wall Thickness, Uroflowmetry, Postvoid Residual Urine, and Prostate Urine. J Urol July 2008, 180(1):250.
  112. Wein AJ: Adjustable Continence Therapy (ProACT): Evolution of the Surgical Technique and Comparison of the Original 50 Patients With the Most Recent 50 Patients at a Single Centre. J Urol July 2008, 180(1):250-251.
  113. Wein AJ: Adjustable Suburethral Sling (Male Remeex System) in the Treatment of Male Stress Urinary Incontinence: A Multicentric European Study. J Urol July 2008, 180(1):251-252.
  114. Wein AJ: Botulinum Toxin A Improves the Quality of Life of Patients With Neurogenic Urinary Incontinence. J Urol July 2008, 180(1):252.
  115. Wein AJ: Effects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin on Bladder Afferent Activity of the Rat Pelvic Nerve. J Urol July 2008, 180(1):407.
  116. Wein AJ: Urodynamics and Stress Urinary Incontinence: The Dark Side of a Gold Standard. J Urol Aug 2008, 180(2):630.
  117. Wein AJ: Detrusor Overactivity Does Not Predict Outcome of Sacral Neuromodulation Test Stimulation. J Urol Aug 2008, 180(2):630-631.
  118. Wein AJ: Human Idiopathic and Neurogenic Overactive Bladders and the Role of M2 Muscarinic Receptors in Contraction. J Urol Aug 2008, 180(2):631.
  119. Wein AJ: The Function of Suburothelial Myofibroblasts in the Bladder. J Urol Aug 2008, 180(2)631-632.
  120. Wein AJ: Diabetic Cystopathy. J Urol Aug 2008, 180(2):632.
  121. Wein AJ: LUTS Treatment: Future Treatment Options. J Urol Sept 2008, 180(3)1047.
  122. Wein AJ: Repeated Botulinum-A Toxin Injections in the Treatment of Myelodysplastic Children and Patients With Spinal Cord Injuries With Neurogenic Bladder Dysfunction. J Urol Sept 2008, 180(3)1047-1048.
  123. Wein AJ: Dysfunctional Voiding Confirmed by Transdermal Perineal Electromyography, and its Effective Treatment With Baclofen in Women With Lower Urinary Tract Symptoms: A Randomized Double-Blind Placebo-Controlled Crossover Trial. J Urol Sept 2008, 180(3)1048-1049.
  124. Wein AJ: 1) Is Abuse Causally Related to Urologic Symptoms? Results From the Boston Area Community Health (BACH) Survey. 2) Beyond the Lower Urinary Tract: The Association of Urologic and Sexual Symptoms With Common Illnesses. J Urol Sept 2008, 180(3)1049-1050.
  125. Wein AJ: Functional and Histological Changes After Myoblast Injections in the Porcine Rhabdosphincter. J Urol Sept 2008, 180(3)1180-1181.
  126. Wein AJ: 1) Overactive Bladder in Diabetes: A Peripheral or Central Mechanism? 2) Bladder Dysfunction in Type 2 Diabetic Patients. J Urol Oct 2008, 180(4)Part 1:1409-1410.
  127. Wein AJ: Duloxetine Compared With Placebo for Treating Women With Symptoms of Overactive Bladder. J Urol Oct 2008, 180(4)Part 1:1410-1411.
  128. Wein AJ: Augmented Repairs and Use of Interposition Grafts in Pelvic Reconstructive Surgery: Part II. J Urol Oct 2008, 180(4)Part 1:1411-1412.
  129. Wein AJ: Robotics and Laparoscopy for Vaginal Prolapse and Incontinence. J Urol Oct 2008, 180(4)Part 1:1412-1413.
  130. Wein AJ: Do Overactive Bladder Symptoms Improve After Repair of Anterior Vaginal Wall Prolapse? J Urol Oct 2008, 180(4)Part 1:1413.
  131. Wein AJ: Treatment Outcome of Tension-Free Vaginal Tape in Stress Urinary Incontinence: Comparison of Intrinsic Sphincter Deficiency and Nonintrinsic Sphincter Deficiency Patients. J Urol Oct 2008, 180(4)Part 1:1413-1414.
  132. Wein AJ: Update on Detrusor Hyperactivity With Impaired Contractility. J Urol Nov 2008, 180(5)2097-2098.
  133. Wein AJ: Beta3-Adrenoceptors in Urinary Bladder. J Urol Nov 2008, 180(5)2098.
  134. Wein AJ: Outcomes and Quality of Life of Adults Undergoing Continent Catheterizable Vesicostomy for Neurogenic Bladder. J Urol Nov 2008, 180(5)2098-2099.
  135. Wein AJ: The Relationship Between Objective Frequency-Volume Chart Data and the I-PSS in Men With Lower Urinary Tract Symptoms. J Urol Nov 2008, 180(5)2099.
  136. Wein AJ: Surgery Insight: Surgical Management of Postprostatectomy Incontinence—The Artificial Urinary Sphincter and Male Sling. J Urol Nov 2008, 180(5)2100.
  137. Wein AJ: Adherence to the 1997 American Urological Association Guidelines for the Surgical Treatment of Stress Urinary Incontinence. J Urol Dec 2008, 180(6)2532.
  138. Wein AJ: Transobturator Tapes for Stress Urinary Incontinence: Results of the Austrian Registry. J Urol Dec 2008, 180(6)2533.
  139. Wein AJ: Transobturator Tape Compared with Tension-Free Vaginal Tape for the Treatment of Stress Urinary Incontinence: A Randomized Controlled Trial. J Urol Dec 2008, 180(6)2533-2534.
  140. Wein AJ: The Use of Synthetic Sub-Urethral Slings in the Treatment of Female Stress Urinary Incontinence. J Urol Dec 2008, 180(6)2534-2535.
  141. Wein AJ: A Randomised Controlled Trial Comparing Two Autologous Fascial Sling Techniques for the Treatment of Stress Urinary Incontinence in Women: Short, Medium and Long-Term Follow Up. J Urol Dec 2008, 180(6)2535-2536.
  142. Wein AJ: A Prospective, Single-Sling, Randomized Crossover Trial of Sacral vs Pudenal Nerve Stimulation for Interstitial Cystitis. J Urol Jan 2009, 181(1)137-138.
  143. Wein AJ: Update on Bladder Evaluation Recommendations and Bladder Management Guideline in Patients with Spinal Cord Injury. J Urol Jan 2009, 181(1)184-185.
  144. Wein AJ: The Immediate and 6-Mo Reproducibility of Pressure-Flow Studies in Men With Benign Prostatic Enlargement. J Urol Jan 2009, 181(1)238-239.
  145. Wein AJ: The Function of Suburothelial Myofibroblasts in the Bladder. J Urol Feb 2009, 181(2)915-916.
  146. Wein AJ: Functional and Histological Changes After Myoblast Injections in the Porcine Rhabdosphincter. J Urol Feb 2009, 181(2)916-917.
  147. Wein AJ: 1) Changes of Gap Junctional Cell-Cell Communication in Overactive Detrusor in Rats. 2) Bladder Afferent Sensitivity in Wild-Type and TRPV1 Knockout Mice. 3)Increased Expression of Transient Receptor Potential Vanilloid Subfamily 1 in the Bladder Predicts the Response to Intravesical Instillations of Resiniferatoxin in Patients With Refractory Idiopathic Detrusor Overactivity. J Urol Mar 2009, 181(3)1495-1498.
  148. Wein AJ: Urgency Assessment in the Evaluation of Overactive Bladder (OAB). J Urol Apr 2009, 181(4)1800-1801.
  149. Wein AJ: Botulinum Toxin A (Botox) Intradetrusor Injections in Adults With Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review. J Urol Apr 2009, 181(4)1802.
  150. Wein AJ: Changes in Urinary Bladder Smooth Muscle Function in Response to Colonic Inflammation. J Urol Apr 2009, 181(4)1957-1958.
  151. Wein AJ: Impact of Overactive Bladder on the Brain: Central Sequelae of a Visceral Pathology. J Urol Apr 2009, 181(4)1958.
  152. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey MR, Sonnad SS, Wein AJ, Malkowicz SB. Defining Pathologic Parameters to Predict Biochemical Failure in Patients with Positive Surgical Margins at Radical Prostatectomy: Implications for Adjuvant Radiation Therapy. Abstract 151 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  153. Coyne KS, Sexton CC, Weinstein D, Kopp ZS, Ebel-Bitoun C, Milsom I, Wein AJ, Chapple CR. The Prevalence of OAB in the US, UK, and Sweden: Results from EPILUTS. Abstract 446 -presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  154. Ravishankar J, Chhatre S, Wein AJ, Malkowicz SB. Cost-Effectiveness of Prostate Cancer Curative Treatment Among Younger Patients. Abstract 547 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  155. Mucksavage P, Van Arsdalen K, Wein AJ, Malkowicz SB. Characteristics of Very Late Biochemical Failure After Radical Retropubic Prostatectomy. Abstract 586 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  156. Mucksavage P, Magerfleisch L, Van Arsdalen K, Wein AJ, Malkowicz SB. Waiting Times to Nephrectomy Does Not Significantly Affect Recurrence. Abstract 982 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  157. Ettickan B, Zderic SA, Wein AJ, Chacko S. Transcription Factor NF-KB Mediates the Gene Expression of Proteins Involved in the Regulation of Calcium Sensitization Pathway in Partial Bladder Outlet Obstruction in Mice. Abstract 1511 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  158. Alanzi JA, Gomes CM, Chang S, Malkowicz SB, Wein AJ, Chacko S. Changes in Myosin Heavy Chain Isoforms and Proteins Involved in CA2+ Sensitization Pathway in the Detrusor Smooth Muscle from Men with Outlet Obstruction Induced by Benign Prostatic Hyperplasia. Abstract 1513 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  159. Chang S, Basha M, Wein AJ, Chacko S. Estrogen-Depletion Down-Regulates Protein Kinase C Pathway in Female Urethral Smooth Muscle. Abstract 1535 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  160. Ettickan B, Gomes CM, Malkowicz SB, Alanzi JA, Wein AJ, Chacko S. Down-Regulation of Caveolin Gene Expression in Detrusor Smooth Muscle From Men with Benign Prostatic Hyperplasia (BPH)-Induced Bladder Outlet Obstruction. Abstract 1574 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  161. Chang S, John M, Hypolite JA, Zderic SA, Wein AJ, Chacko S. Temporal Changes of Intermediate Filament Proteins in Obstruction-Induced Detrusor Remodeling. Abstract 1577 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009
  162. Brucker BM, Spence A, Resnick MJ, Pukenas B, Van Arsdalen K, Wein AJ, Malkowicz SB, Ramchandani P. Ureteral Pseudodiverticula: Associated with Urothelial Malignancy. Abstract 2149 - presented at the Annual Meeting of the American Urological Association Meeting, Chicago, IL, April 2009.
  163. Wein AJ. Periurethral Injection Therapy for Urinary Incontinence in Women. J Urol May 2009 181(5)2223-2224.
  164. Wein AJ. Systematic Review: Randomized, Controlled Trials of Nonsurgical Treatments for Urinary Incontinence in Women. J Urol May 2009, 181(5)2224-2225.
  165. Wein AJ. The Neural Control of Micturition. J Urol May 2009, 181(5)2225.
  166. Wein AJ. 1) Cluster Analysis and Lower Urinary Tract Symptoms in Men: Findings From the Boston Area Community Health Survey. 2) Do Urological Symptoms Cluster Among Women? Results From the Boston Area Community Health Survey. 3) Examining Lower Urinary Tract Symptom Constellations Using Cluster Analysis. 4) Beyond the Cluster: Methodological and Clinical Implications in the Boston Area Community Health Survey and EPIC Studies. J Urol May 2009, 181(5) 2225-2228.
  167. Wein AJ. The Uroepithelial-Associated Sensory Web. J Urol June 2009, 181(6)2563..
  168. Wein AJ. Ketamine-Associated Ulcerative Cystitis: A New Clinical Entity. J Urol June 2009, 181(6)2564.
  169. Wein AJ. Loss of Prostaglandin E2 Release From Immortalized Urothelial Cells Obtained From Interstitial Cystitis Patient Bladders. J Urol June 2009, 181(6)2564-2565.
  170. Wein AJ. Does the Patient’s Position Influence the Detection of Detrusor Overactivity? J Urol June 2009, 181(6)2647-2648.
  171. Wein AJ. How Should Patients With an Overactive Bladder Manipulate Their Fluid Intake? J Urol June 2009, 181(6)2648-2649.
  172. Wein AJ. Emerging Pharmacological Targets in Overactive Bladder Therapy: Experimental and Clinical Evidences. J Urol June 2009, 181(6)2649.
  173. Wein AJ. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. J Urol June 2009, 181(6)2649-2650.
  174. Wein AJ. Spinal-Injured Neuropathic Bladder Antisepsis (SINBA) Trial. J Urol July 2009, 182(1)164.
  175. Wein AJ. The Aetiology of Prolapse. J Urol July 2009, 182(1)229.
  176. Wein AJ. Incidence of Recurrent Pelvic Organ Prolapse 10 Years Following Primary Surgical Management: A Retrospective Cohort Study. J Urol July 2009, 182(1)229-230.
  177. Wein AJ. Long-Term Patient Satisfaction With Prolapse Surgery in General Gynecology. J Urol July 2009, 182(1)230.
  178. Wein AJ. Sexual Function After Vaginal Surgery for Pelvic Organ Prolapse and Urinary Incontinence. J Urol July 2009, 182(1)231.
  179. Wein AJ. Surgical Management of Pelvic Organ Prolapse in Women. J Urol July 2009, 182(1)231-233.
  180. Wein AJ. Mixed Incontinence is More Bothersome Than Pure Incontinence Subtypes. J Urol Aug 2009, 182(2)633.
  181. Wein AJ. Botulinum Neurotoxin Type A in Urology: Antibiotics as a Cause of Therapy Failure. J Urol Aug 2009, 182(2)634.
  182. Wein AJ. Efficacy and Safety of Duloxetine in Elderly Women With Stress Urinary Incontinence or Stress-Predominant Mixed Urinary Incontinence. J Urol Aug 2009, 182(2)634-635.
  183. Wein AJ. Mechanical Devices for Urinary Incontinence in Women. J Urol Aug 2009,182(2)635-636.
  184. Wein AJ. Tension-Free Vaginal Tape Versus Colposuspension for Primary Urodynamic Stress Incontinence: 5-Year Follow Up. J Urol Aug 2009, 182(2)636-637.
  185. Wein AJ. Efficacy and Safety of Extended-Release Oxybutynin in Combination With Tamsulosin for Treatment of Lower Urinary Tract Symptoms in Men: Randomized, Double-Blind, Placebo-Controlled Study. J Urol Aug 2009, 182(2)637-638.
  186. Wein AJ. Activation and Inhibition of the Micturition Reflex by Penile Afferents in the Cat. J Urol Aug 2009, 182(2)796.
  187. Wein AJ. Postpartum Depression, Urge Urinary Incontinence, and Overactive Bladder Syndrome: Is There an Association? J Urol Sept 2009, 182(3)1083.
  188. Wein AJ. A Review of Adherence to Drug Therapy in Patients With Overactive Bladder. J Urol Sept 2009, 182(3)1084.
  189. Wein AJ. Validation of Treatment Benefit Scale for Assessing Subjective Outcomes in Treatment of Overactive Bladder. J Urol Sept 2009, 182(3)1084-1085.
  190. Wein AJ. A Prospective Assessment of Overactive Bladder Symptoms in a Cohort of Elderly Women Who Underwent Transvaginal Surgery for Advanced Pelvic Organ Prolapse. J Urol Sept 2009, 182(3)1085-1086.
  191. Wein AJ. Timed Voiding for the Management of Urinary Incontinence in Adults. J Urol Oct 2009, Part 1 of 2, 182(4)1469-1470.
  192. Wein AJ. 1) A Randomized Trial Comparing TVT With TVT-O: 12-Month Results; 2) Eleven Years Prospective Follow-Up of the Tension-Free Vaginal Tape Procedure for Treatment of Stress Urinary Incontinence. J Urol Oct 2009 Part 1 of 2, 182(4)1470-1471.
  193. Wein AJ. A Multi-Centre, Randomised Clinical Control Trial Comparing the Retropubic (RP) Approach Versus the Transobturator Approach (TO_ for Tension-Free, Suburethral Sling Treatment of Urodynamic Stress Incontinence: The TORP Study. J Urol Oct 2009 Part 1 of 2, 182(4)1471.
  194. Wein AJ. Resiniferatoxin in the Treatment of Interstitial Cystitis: A Systematic Review. J Urol Nov 2009, 182(5):2328-2329.
  195. Wein AJ. The Long-Term Effectiveness of Antenatal Pelvic Floor Muscle Training: Eight-Year Follow Up of a Randomised Controlled Trial. J Urol Nov 2009, 182(5):2415.
  196. Wein AJ. On the Origin of Bladder Sensing: TR(1)Ps in Urology. J Urol Nov 2009, 182(5):2529.
  197. Wein AJ. Basic Fibroblast Growth Factor Modulates Proliferation and Collagen Expression in Urinary Bladder Smooth Muscle Cells. J Urol Nov 2009, 182(5):2529-2530.
  198. Wein AJ. Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women. J Urol Dec 2009 Part 1 of 2, 182(6):2836.
  199. Wein AJ. The Management of Voiding Dysfunction in Persons with Dementia. J Urol Dec 2009 Part 1 of 2, 182(6):2837.
  200. Wein AJ. Neurogenic Bladder From Multiple Sclerosis. J Urol Dec 2009 Part 1 of 2, 182(6):2837-2838.
  201. Wein AJ. The Impact of Lower Urinary Tract Symptoms and Urinary Incontinence on Female Sexual Dysfunction Using a Validated Instrument. J Urol Dec 2009 Part 1 of 2, 182(6):2864.
  202. Wein AJ. Urinary Incontinence in Women: Direct Costs of Routine Care. J Urol Jan 2010, 183(1):253.
  203. Wein AJ. The Impact of Multichannel Urodynamics Upon Treatment Recommendations for Female Urinary Incontinence. J Urol Jan 2010, 183(1):253-254.
  204. Wein AJ. Reliability Testing of Urodynamics, Pressure Flow Studies and Cough Leak Point Pressure in Women With Urodynamic Stress Incontinence With and Without Detrusor Overactivity. J Urol Jan 2010, 183(1):254.
  205. Wein AJ. Clarification and Confirmation of the Knack Maneuver: The Effect of Volitional Pelvic Floor Muscle Contraction to Preempt Expected Stress Incontinence. J Urol Jan 2010, 183(1):255.
  206. Wein AJ. Radiofrequency Remodelling of the Endopelvic Fascia is Not an Effective Procedure for Urodynamic Stress Incontinence in Women. J Urol Jan 2010, 183(1):255-256.
  207. Wein AJ. Rate of De Novo Stress Urinary Incontinence After Urethral (sic) Diverticulum Repair. J Urol Jan 2010, 183(1)256-257.
  208. Wein AJ. Surgical Management of Pelvic Organ Prolapse in Women: A Short Version Cochrane Review. J Urol Jan 2010, 183(1):257-258.
  209. Wein AJ. Short-Term Results of Bilateral S2-S4 Sacral Neuromodulation for the Treatment of Refractory Interstitial Cystitis, Painful Bladder Syndrome, and Chronic Pelvic Pain. J Urol Feb 2010, 183(2):570.
  210. Wein AJ. A Positive Modulator of KCa2 and KCa3 Channels, 4,5-Dichloro-1,3-Diethyl-1,3-Dihydro-Benzoimidazol-2-One (NS4591), Inhibits Bladder Afferent Firing in Vitro and Bladder Overactivity In Vivo. J Urol Feb 2010, 183(2):646.
  211. Wein AJ. Sacral Nerve Stimulation for Neuromodulation of the Lower Urinary Tract. J Urol Feb 2010, 183(2):646-647.
  212. Wein AJ. Does Urodynamic Verification of Overactive Bladder Determine Treatment Success? Results from a Randomized Placebo-Controlled Study. J Urol Feb 2010, 183(2):647-648.
  213. Wein AJ. Catecholamines Relax Detrusor Through ?2-Adrenoceptors in Mouse and ?3-Adrenoceptors in Man. J Urol Feb 2010, 183(2):823.
  214. Wein AJ. Do Women With Pure Stress Urinary Incontinence Need Urodynamics? J Urol Mar 2010, 183(3):1110-1111.
  215. Wein AJ. Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months. J Urol Mar 2010, 183(3):1111-1112.
  216. Wein AJ. A Systematic Review of Overweight and Obesity as Risk Factors and Targets for Clinical Intervention for Urinary Incontinence in Women. J Urol Apr 2010, 183(4):1479-1480.
  217. Wein AJ. Basic Mechanisms of Urgency: Preclinical and Clinical Evidence. J Urol Apr 2010, 183(4):1480-1481.
  218. Wein AJ. Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. J Urol May 2010, 183(5):1927-1928.
  219. Wein AJ. Urinary and Erectile Dysfunction in Multiple System Atrophy (MSA). J Urol May 2010, 183(5):1928-1929.
  220. Wein AJ. Prophylactic Antibiotics in Urodynamics: A Systematic Review of Effectiveness and Safety. J Urol June 2010, 183(6):2275.
  221. Wein AJ. Evaluation and Outcome Measures in the Treatment of Female Urinary Stress Incontinence: International Urogynecological Association (IUGA) Guidelines for Research and Clinical Practice. J Urol June 2010, 183(6):2276.
  222. Wein AJ. Nocturia, Nocturnal Incontinence Prevalence, and Response to Anticholinergic and Behavioral Therapy. J Urol June 2010, 183(6):2277.
  223. Wein AJ. Enhanced Bladder Capacity and Reduced Prostaglandin E2-Mediated Bladder Hyperactivity in EP3 Receptor Knockout Mice. J Urol June 2010, 183(6):2463-2464.
  224. Wein AJ. Long-Lasting Breaches in the Bladder Epithelium Lead to Storage Dysfunction With Increase in Bladder PGE2 Levels in the Rat. J Urol June 2010, 183(6):2464-2465.
  225. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S. Role of Myosin Light Chain Phosphorylation in Partial Bladder Outlet Obstruction: Compensated Versus Decompensated. Abstract 183, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010.
  226. Hypolite J, Chang S, Zderic S, Wein A, Butler S, Chacko S. Large Conductance Calcium-And Voltage-Activated Potassium Channel (BK) Opener Inhibits Spontaneous Overactive Contraction of Detrusor Smooth Muscle in Obstructed Bladders. Abstract 186, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010.
  227. Resnick M, Lee D, Van Arsdalen K, Wein A, Malkowicz SB, Guzzo T. Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer. Abstract 247, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 30, 2010.
  228. Stansell L, Newman D, Magerfleisch L, Wein A, Guzzo T, Malkowicz SB. Increased Basal Resting Tone During EMG Biofeedback is Associated with Improved Voiding for Patients with Orthotopic Neobladder Dysfunction. Abstract 749, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010.
  229. Asfaw T, Hypolite J, Northington G, Arya L, Wein A, Malykhina A. Diminished Detrusor Muscle Contractility Underlies the Urinary Bladder Dysfunction Induced by Experimental Colitis: Mechanism For Pelvic Organ Cross-Talk. Abstract 1001, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010.
  230. Lei Q, Pan X-Q, Wein A, Malykhina A. Acute Inflammation in the Pelvis Modulates the Excitability of Bladder Extrinsic Sensory Neurons Via Activation of Voltage Gated Sodium Channels and Non-Selective Cation Channels. Abstract 1002, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010.
  231. Chang S, Alanzi J, Hanno PM, Newman DK, Northington G, Wein AJ, Chacko S. Endothelin-1 as a Regulator of Urothelial Cell Proliferation and a Potential Urinary Biomarker in Interstitial Cystitis(ic). Abstract 1042, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, May 31, 2010.
  232. Boopathi E, Hypolite J, Liou H-C, Wein A, Chacko S. Transcription Factor NF-KB is Required for Gene Expression of a 17-KDA PKC-Potentiated Inhibitory Protein of Protein Phosphatase-1 (CPI-17) and PKC-Mediated Signal Transduction of Detrusor Smooth Muscle Contraction. Abstract 1685, presented at the Annual Meeting of the American Urological Association, San Francisco, CA, June 1, 2010.
  233. Wein AJ. Gene Therapy for Bladder Overactivity and Nociception With Herpes Simplex Virus Vectors Expressing Preproenkephalin. J Urol July 2010, 184(1):224.
  234. Wein AJ. Neuromuscular Electrical Stimulation and the Treatment of Lower Urinary Tract Dysfunction in Multiple Sclerosis – A Double Blind, Placebo Controlled, Randomised Clinical Trial. J Urol July 2010, 184(1):225.
  235. Wein AJ. 1) Botulinum Injections for the Treatment of Bladder Symptoms of Multiple Sclerosis; 2) Neurogenic Detrusor Overactivity Treated With English Botulinum Toxin A: 8-Year Experience of One Single Centre. J Urol July 2010, 184(1):226-227.
  236. Wein AJ. Bladder Diary Measurements in Asymptomatic Males: Frequency, Volume per Void, and 24-Hr Volume. J Urol August 2010, 184(2):643.
  237. Wein AJ. Do alpha1-Adrenoceptor Antagonists Improve Lower Urinary Tract Symptoms by Reducing Bladder Outlet Resistance? J Urol August 2010, 184(2):643-644.
  238. Wein AJ. Ileovesicostomy for Adults With Neurogenic Bladders: Complications and Potential Risk Factors for Adverse Outcomes. J Urol August 2010, 184(2):644-645.
  239. Wein AJ. Incontinent Ileovesicostomy: Long-Term Outcomes and Complications. J Urol August 2010, 184(2):645-646.
  240. Wein AJ. Prospective Pharmacologic Therapies for the Overactive Bladder. J Urol August 2010, 184(2):800-801.
  241. Wein AJ. 1) The Evolving Physiology of the Lower Urinary Tract: What We are Learning and Where We Need to Go. 2) Antihyperalgesic Effects of (R,E)-N-(2-Hydroxy-2,3-Dihydro-1H-Inden-4-yl)-3-(2-(Piperidin-1-yl)-4-(Trifluoromethyl)Phenyl)-Acrylamide (AMG8562), a Novel Transient Receptor Potential Vanilloid Type 1 Modulator That Does Not Cause Hyperthermia in Rats. 3) AMTB, a TRPM8 Channel Blocker: Evidence in Rats for Activity in Overactive Bladder and Painful Bladder Syndrome. J Urol August 2010, 184(2):801-803.
  242. Wein AJ. 1) Chronic Suprapubic Catheterization in the Management of Patients With Spinal Cord Injuries: Analysis of Upper and Lower Urinary Tract Complications. 2) Contemporary Role of Suprapubic Cystostomy in Treatment of Neuropathic Bladder Dysfunction in Spinal Cord Injured Patients. J Urol September 2010, 184(3):997-999.
  243. Wein AJ. Defining Success Following Sling Surgery: Association of Satisfaction With Patient Reported Outcomes. J Urol September 2010, 184(3):1045-1046.
  244. Wein AJ. Predictors of Persistent Detrusor Overactivity After Transvaginal Sling Procedures. J Urol September 2010, 184(3):1046-1047.
  245. Wein AJ. Pregnancy and Delivery After Mid-Urethral Sling Procedures for Stress Urinary Incontinence: Case Reports and a Review of Literature. J Urol September 2010, 184(3):1047-1048.
  246. Wein AJ. Follow-Up of TVT Operations in 1,113 Women With Mixed Urinary Incontinence at 7 and 38 Months. J Urol September 2010, 184(3):1048.
  247. Wein AJ. A 5-Year Prospective Follow-Up Study of Vaginal Surgery for Pelvic Organ Prolapse. J Urol September 2010, 184(3):1049.
  248. Wein AJ. Sacral Neuromodulation for Urinary Retention. J Urol September 2010, 184(3):1049-1050.
  249. Wein AJ. Is it possible to diagnosis intrinsic sphincter deficiency in women? J Urol October 2010, 184(4):1419.
  250. Wein AJ. A review of the concordance of diagnoses made after multi-channel urodynamics and video urodynamics in women with urinary incontinence. J Urol October 2010, 184(4):1420.
  251. Wein AJ. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: The Colpopexy and urinary reduction efforts (CARE) randomized surgical trial. J Urol October 2010, 184(4):1421.
  252. Wein AJ. “The Cough Game”: Are there characteristic urethrovesical movement patterns associated with stress incontinence? J Urol October 2010, 184(4):1421-1422.
  253. Wein AJ. Obstructive voiding symptoms are not predictive of elevated postvoid residual urine volumes. J Urol October 2010, 184(4):1422-1423.
  254. Wein AJ. Differences between the data from free flow and intubated flow in women with urinary incontinence. What do they mean? J Urol October 2010, 184(4):1423.
  255. Wein AJ. Bladder Control, Urgency, and Urge Incontinence: Evidence From Functional Brain Imaging. J Urol November 2010, 184(5):2029.
  256. Wein AJ. Practical Aspects of Lifestyle Modifications and Behavioural Interventions in the Treatment of Overactive Bladder and Urgency Urinary Incontinence. J Urol November 2010, 184(5):2030.
  257. Wein AJ. Randomized, Placebo-Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended-Release Oxybutynin in Cognitively Impaired Nursing Home Residents With Urge Urinary Incontinence. J Urol November 2010, 184(5):2030-2031.
  258. Wein AJ. Has Botulinum Toxin Therapy Come of Age: What Do We Know, What Do We Need to Know, and Should We Use It? J Urol November 2010, 184(5):2031-2032.
  259. Wein AJ. Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report. J Urol November 2010, 184(5):2032-2033.
  260. Wein AJ. Duloxetine 1 Year On: The Long-Term Outcome of a Cohort of Women Prescribed Duloxetine. J Urol November 2010, 184(5):2033.
  261. Wein AJ. The Destruction of the Lower Urinary Tract by Ketamine Abuse: A New Syndrome? J Urol November 2010, 184(5):2034.
  262. Wein AJ. Effect of Long-Term Oxybutynin Administration on C-Fos Expression in Spinal Neurons: Inhibition of Antimuscarinics on Bladder Afferents in Conscious Rats. J Urol November 2010, 184(5):2209-2210.

Dr. Alan Wein

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine